The Secretariat has received 93 requests for funding in the first application window of the 2017-2019 funding cycle, according to the Global Fund’s Funding Request Status Tracker. Under the Global Fund’s differentiated application system, 73 requests used a program continuation application, 13 a full review application, and seven a tailored review application. There are different types of tailored reviews. Four applicants filed a tailored-to-material-change request; two a tailored-to-national-strategy-based pilots request; and one a tailored-to-transition request. No applications were received using the fourth type of tailored review: tailored to challenging operating environments. (See GFO article for more information on the different types of request.) See the table below for a list of components for which funding requests were received in Window 1. The deadline for submitting funding requests for Window 1 was 20 March 2017. Deadlines have also been established for three more windows, as follows: Window 2 – 23 May 2017 Window 3 – 28 August 2017 Window 4 – 31 January 2018 It is expected that additional windows will be added in 2018 and 2019. Funding requests submitted in Window 1 will be reviewed by the Technical Review Panel (TRP) between 23 April and 2 May 2017. The Secretariat is expected to eventually post copies of the funding requests on its website, but only once agreements are signed for the grants emanating from the requests.

Full Review: Bangladesh HIV, TB, malaria Malawi malaria Nigeria malaria	Philippines HIV, TB RAI malaria		Uganda HIV, TB, malaria Zimbabwe TB/HIV, malaria
Program Continuation: Afghanistan HIV, malaria Azerbaijan HIV, TB Benin HIV, TB, malaria Burkina Faso HIV, TB, malaria Burundi HIV, TB, malaria Cameroon malaria Cape Verde TB/HIV, malaria CAR malaria Chad malaria Congo DR malaria Côte d’Ivoire TB, malaria Eritrea malaria Gambia, TB/HIV, malaria Guinea HIV, malaria Guinea-Bissau TB/HIV, malaria Guyana HIV	Haiti TB/HIV, malaria Honduras malaria Indonesia malaria Iran HIV Kyrgyzstan HIV, TB Lesotho TB/HIV Liberia malaria Madagascar HIV, TB, malaria Mali TB/HIV Moldova HIV, TB Mongolia HIV Mozambique malaria Multi-C. W. Pacific TB/HIV, malaria Nicaragua HIV Niger HIV, malaria		Pakistan malaria PNG malaria Paraguay HIV Philippines malaria Sénégal HIV, malaria S. Leone HIV, TB, malaria, RSSH Solomon Islands TB, malaria Somalia malaria Sudan TB/HIV and malaria Suriname malaria Swaziland malaria Timor Leste TB Togo TB/HIV, malaria Uzbekistan HIV, TB Zanzibar TB/HIV, malaria

Tailored Review: Congo DR TB/HIV (material change) Lao TB (material change) Malawi TB/HIV (material change)

Mauritius HIV (material change) Rwanda TB/HIV, malaria (NSP pilot) Cuba HIV (transition)

Program continuation is the simplest type of funding request. It involves submitting a letter (as opposed to a full application form) and completing a short template requesting funding for an additional three years under substantially the same goals and strategic objectives – and under similar interventions – as the current grant. Use of the program continuation approach is limited to applicants that meet certain criteria, such as strong programmatic performance and absorption, a low risk profile, and no need for a material change in programming. All program continuation requests had to be submitted in Window 1 (for grants ending up to 30 June 2018) or Window 4 (for grants ending on or after 1 July 2018). When it reviews a program continuation request, the TRP will recommend that it proceed to the grant-making stage provided it considers that the request does not involve any material change. The TRP may recommend that certain issues be addressed during grant-making. If the TRP believes that that the request involves material change, it may recommend that the applicant develop a tailored or full funding request instead. For tailored and full review requests, the Global Fund estimates that the process from funding request to grant signing may take, on average, nine months. When the TRP assesses these requests, the outcome will be one of the following:

• 
  Proceed to grant-making:
   The funding request is determined to be strategically focused and technically sound, although the applicant might need to provide clarifications or make adjustments; or
• 
  Re-submit funding request iteration:
   The applicant should address the comments raised by the TRP in a revised funding request to be re-submitted for a second TRP review prior to advancing to grant-making.

Other developments

The information in this section is taken from the Global Fund’s 

2017-2019 Funding Cycle: Frequently Asked Questions.
If an applicant chooses to go for a grant that is less than three years’ duration, the allocation is reduced proportionately. In other words, if an applicant submits a funding request covering just two years, it will receive just two-thirds of what it was originally allocated. This is a change from the previous funding cycle. Presumably, the Global Fund wants to avoid the problems created by shortened grants in the 2014-2016 funding cycle. All applicants are required to prepare a prioritized above-allocation request (PAAR) that can be assessed for unfunded quality demand. For full- and tailored-review applications, the PAAR must be submitted with the funding request and may be updated during grant-making or grant implementation. For program continuation applications, the PAAR may be submitted with the program continuation request, during grant-making or during grant implementation, and may also be updated during grant-making or grant implementation. In line with the differentiated approach the Global Fund has adopted for managing grants and other aspects of the funding model, the Fund has categorized countries as “core,” “focused” or “high impact.” GFO has written about this before here. The categorization is revised every allocation period. A list of countries in each category for the 2014-2016 allocation period is available in the Operational Policy Manual. See the “Overview of the Operational Policy Manual” section near the beginning of the manual.